tiprankstipranks
Love Pharma Inc (TSE:JOLT)
:JOLT
Canadian Market

Love Pharma Inc (JOLT) Financial Statements

Compare
7 Followers

Love Pharma Inc Financial Overview

Love Pharma Inc's market cap is currently C$636.45K. The company's EPS TTM is C$-0.008; its P/E ratio is ―; Love Pharma Inc is scheduled to report earnings on April 30, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Sep 20Sep 19
Income Statement
Total Revenue
Gross Profit-----
Operating Income$ -415.74K$ -1.66M$ -8.24M$ -128.30K$ -329.88K
EBITDA$ -748.52K$ -3.56M$ -9.47M$ -128.30K$ -329.88K
Net Income$ -765.74K$ -3.58M$ -9.52M$ -128.30K$ -329.88K
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 372.43K$ 821.29K$ 1.82M$ 693.04K$ 532.46K
Total Debt$ 0.00$ 145.27K$ 223.68K$ 0.00$ 0.00
Net Debt$ -2.06K$ 103.66K$ -111.10K$ -13.29K$ -7.46K
Total Liabilities$ 499.34K$ 633.48K$ 606.11K$ 130.13K$ 184.42K
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -122.08K$ -2.09M$ -1.41M$ -182.59K$ -311.77K
Operating Cash Flow$ -122.08K$ -1.50M$ -1.41M$ -182.59K$ -311.77K
Investing Cash Flow
Financing Cash Flow
Currency in USD

Love Pharma Inc Earnings and Revenue History

Love Pharma Inc Debt to Assets

Love Pharma Inc Cash Flow

Love Pharma Inc Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis